Brii Biosciences Limited (BRIBF)
OTCMKTS · Delayed Price · Currency is USD
0.2600
-0.0072 (-2.69%)
At close: May 5, 2025

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22
Therapies for Infectious Diseases and Central Nervous System Diseases
681.78K
Log In
Therapies for Infectious Diseases and Central Nervous System Diseases Growth
-98.86%
Log In

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22
China
681.78K
Log In
China Growth
-98.86%
Log In